Powered by: Motilal Oswal
2026-05-12 09:39:36 am | Source: Religare Broking Ltd
Trade Idea of The Day - Sun Pharmaceutical Industries Ltd Target Rs.56 - Religare Broking Ltd
Trade Idea of The Day - Sun Pharmaceutical Industries Ltd Target Rs.56 - Religare Broking Ltd

Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd BUY 26 MAY 1860 CALL SELL 26 MAY 1940 CALL Entry Range 20 – 24 Target Range 56 Stop Loss 10

Rationale

• On the daily chart SUNPHARMA has witnessed a strong bullish breakout above the 1850 mark, indicating renewed buying momentum after a prolonged consolidation phase. Sustained trading above this level may trigger further upside traction in the near term.

• From the technical prospect, prices are comfortably trading above its 20-DEMA and 50-DEMA, reflecting a positive trend structure. The short-term moving averages are also supporting the ongoing upward momentum.

• Momentum indicators remain constructive, as RSI is gradually moving towards the bullish zone near 60, while MACD has generated a positive crossover with rising histogram bars, confirming strengthening price momentum.

• For the near term one can adopt a buy-on-dip strategy near the 1840-1850 support zone to build Bull Call strategy with the upside resistance of 1940 and downside support near the 1800 zone.

 

Please refer disclaimer at https://www.religareonline.com/disclaimer

SEBI Registration number is INZ00017433

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here